PyInvesting

Market research

CHY.F ChemoMetec A/S

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
1B
P/E ratio
46.1
Analyst target
Not available
Dividend yield
11.%
Beta
1.38

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

ChemoMetec A/S is currently in a long term uptrend where the price is trading 55.6% above its 200 day moving average.

From a valuation standpoint, the stock is 213.5% more expensive than other stocks from the Technology sector with a price to sales ratio of 42.8.

Finally, its free cash flow grew by 90.6% to $24M since the same quarter in the previous year.

Based on the above factors, ChemoMetec A/S gets an overall score of 2/5.